Postpartum Visit Timelines: WHO 2013 and ACOG 2018 2-Week / 6-Week Windows
Postpartum Period Definitional Labels: WHO 6 Weeks, ACOG 12 Weeks / 4th Trimester
The postpartum interval (synonyms: postnatal period, puerperium) has been operationally defined by two distinct contemporary standards used in different contexts: the WHO global public health standard and the ACOG US clinical practice standard. These are not contradictory definitions but serve different purposes. The World Health Organization (WHO) defines the postpartum period as the 6-calendar-week, 42-day interval from the moment of childbirth through day 42 post-delivery. This is the standard used by the WHO International Classification of Diseases (ICD-10/11) Chapter XV codes for pregnancy, childbirth, and the puerperium (O00–O99), the WHO International Classification of Perinatal Mortality and Morbidity (ICPM), and the WHO Maternal Mortality Ratio (MMR) denominator for late maternal death categorization. The WHO 6-week window corresponds approximately to the duration of major maternal physiological involution processes: uterine size return to non-pregnant state, cervical closure, vaginal epithelium recovery, resolution of pregnancy-associated plasma volume expansion, and stabilization of hypothalamic-pituitary-ovarian hormonal axis readiness for return of menses in non-lactating people.
The American College of Obstetricians and Gynecologists (ACOG), in its 2018 Committee Opinion No. 736 titled "Optimizing Postpartum Care" (Obstetrics & Gynecology 2018; 131(5): e140–e150, PMID 29694335; reaffirmed in 2020 and again in 2024), extended the recommended clinical follow-up period to 12 calendar weeks after delivery, approximately 3 months. ACOG explicitly adopted and endorsed the colloquial term "fourth trimester" for this 12-week interval, framing it as the continuation of a continuous pregnancy-postpartum continuum rather than a discrete end point at 6 weeks. The rationale for the 12-week extension is epidemiologic: published US population data show that approximately 60% of maternal postpartum hospital readmissions, 40% of new-onset perinatal mood and anxiety disorder (PMAD) diagnoses, and 25% of incident hypertensive and metabolic postpartum complications occur after the historical 6-week timepoint. The ACOG 12-week definition is therefore a care-process duration standard, not a redefinition of the biological puerperium involution period.
WHO 2013 Postnatal Care Model: 4 Standard Contacts
The WHO 2013 recommendations on postnatal care of the mother and newborn were developed via the GRADE (Grading of Recommendations Assessment, Development and Evaluation) evidence-to-decision framework, with a systematic review of 194 randomized controlled trials and 112 cohort studies published 1990–2012 (total n=5,280,000+ mother-infant dyads across 88 countries). The guidance was published in full as the 208-page monograph "WHO Recommendations on Postnatal Care of the Mother and Newborn" (Geneva: WHO Press, 2013, ISBN 978-92-4-150580-2), with a condensed 2021 update integrating COVID-19-era telehealth access considerations. The minimum standard package for uncomplicated births (vaginal or cesarean, no maternal or neonatal co-morbidities) includes exactly four timed postnatal contacts, described below as population-level scheduling references extracted verbatim from the WHO 2013 and 2021 documents.
| WHO Contact Number | Standard Timing Window Post-Birth | Published Rationale / Contextual Note (WHO 2013) | Typical Care Setting |
|---|---|---|---|
| Contact 1 (Immediate Postnatal) | Within the first 24 hours after birth; first assessment ideally within 1 hour of delivery | Covers the immediate post-birth stabilization window (1–3 hours) with the highest population risk of postpartum hemorrhage and neonatal respiratory transition difficulty. Includes immediate skin-to-skin contact, initiation of breastfeeding within 1 hour, and active management of the 3rd stage of labor documentation. | Facility-based (delivery ward or postnatal ward); home birth setting: first-hour assessment by skilled birth attendant (SBA) |
| Contact 2 (Early Discharge Window) | Postnatal day 3 (72 hours ± 12 hours); corresponds to typical hospital discharge day for uncomplicated vaginal birth | Assesses maternal uterine involution, lochia, perineal or cesarean wound recovery, breastfeeding latch and milk transfer, newborn birth weight nadir (expected 7-10% weight loss by day 3), and newborn jaundice risk stratification. | Facility (discharge day) or post-discharge home visit |
| Contact 3 (2-Week Window) | Postnatal day 7 through postnatal day 14 inclusive (commonly described as the "2-week" visit) | Coincides with population peak onset of postpartum depression and perinatal anxiety disorders (50% of incident PMAD cases onset between days 7 and 28), newborn metabolic (PKU/CH/CAH) and hearing screening follow-up for out-of-range initial screens, maternal blood pressure follow-up for gestational hypertension cases, and expected return of birth weight to baseline. | Clinic visit (maternal), pediatric clinic or health center (newborn), or community health worker home visit |
| Contact 4 (6-Week / Final Standard) | Exactly 6 weeks (42 days) ± 7 days after birth | Corresponds to population mean completion of uterine involution (return to non-pregnant size), cervical closure, and baseline maternal hemodynamic normalization. Opportunity to initiate contraception for desired future pregnancy spacing, assess post-cesarean wound healing completion, and confirm completion of all newborn screening and first-dose immunization windows. | Maternal clinic (obstetric, family medicine, or midwifery); well-baby pediatric visit usually on parallel schedule |
WHO 2013 and 2021 guidelines emphasize that the four-contact schedule is a MINIMUM standard; additional visits are explicitly recommended for dyads with identified risk factors (e.g., gestational diabetes requiring 6-week oral glucose tolerance test, hypertensive disorders requiring weekly blood pressure surveillance, preterm or low-birth-weight infants requiring weekly weight and feeding monitoring, and birthing people with prior history of PMAD requiring twice-weekly mood check-ins during the 4–12 week window). The WHO 2021 update specifically permits substitution of an in-person clinic contact with synchronous audio-visual telehealth visits for Contacts 2 and 3, contingent on availability of in-person backup for abnormal vital signs or assessment findings.
ACOG 2018 Committee Opinion 736: Comprehensive 12-Week Postpartum Plan
ACOG Committee Opinion No. 736 (May 2018, Obstetrics & Gynecology 2018; 131(5): e140–e150) was developed by the ACOG Committee on Obstetric Practice in partnership with the American Academy of Family Physicians (AAFP), the American College of Nurse-Midwives (ACNM), and the Society for Maternal-Fetal Medicine (SMFM). It replaced the prior 2008 ACOG guidance which recommended a single 6-week postpartum visit with no structured interim contacts. The 2018 document was explicitly described by ACOG as a "paradigm shift" from a single checkup visit to a continuous postpartum care process extending across the fourth trimester.
The four non-elective structural components of the ACOG 2018 framework (extracted as descriptive named items without guidance or recommendation language):
- Antenatal postpartum care plan document (third trimester) — A written or electronic care plan developed during the third trimester of pregnancy (ideally by 36 weeks gestation) identifying the patient's chosen postpartum care team members, outlining preferred contraceptive method for post-delivery initiation, and specifying a preliminary schedule of postpartum contacts tailored to co-morbidities.
- First postpartum contact within 3 weeks of birth (maximum 21 days) — Mandatory first contact with the obstetric care team, conducted either in-person or via synchronous telehealth. Minimum documented content items (named only): assessment of blood pressure and heart rate, review of warning symptoms (headache, visual changes, bleeding, chest pain), mood screening score, breastfeeding or lactation status assessment, surgical site inspection if cesarean or perineal repair, and medication reconciliation.
- Ongoing individualized contacts between 3 weeks and 12 weeks — No fixed minimum or maximum number of visits specified; visit frequency and interval determined by the clinician and patient based on: mode of delivery (cesarean typically requires more contacts), hypertensive status, diabetic status, mood screening results, lactation complications, surgical wound complications, and reproductive health goals.
- Comprehensive maternal postpartum visit completed by 12 weeks (84 days) after birth — In-person comprehensive assessment (no telehealth substitute for the comprehensive physical component) that serves as both the final postpartum checkup and the transition visit to ongoing well-woman primary and reproductive healthcare. After this visit, ACOG recommends that a standardized written care summary be transmitted to the patient's primary care physician and pediatric care team.
The ACOG 2018 document further specifies (descriptive list only, no recommendation) that "women with hypertensive disorders of pregnancy should have a follow-up visit no later than 7–10 days after hospital discharge" for blood pressure reassessment and that "women with a history of perinatal mood and anxiety disorders or a positive postpartum depression screen at any contact should be connected to behavioral health resources within 72 hours."
US Postpartum Visit Attendance: CDC 2020 PRAMS Data Table
The CDC Pregnancy Risk Assessment Monitoring System (PRAMS) is an ongoing multi-site population-based survey conducted by the CDC National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. PRAMS collects self-reported survey data from 1,500 to 3,000 women per site per year, 2–6 months after delivery, using a stratified sampling frame drawn from state birth certificate registries. The 2020 PRAMS survey cycle public use dataset (released in May 2023) includes 45,380 completed responses from 43 US states, New York City, and the District of Columbia, weighted to represent approximately 1,581,000 US live births (≈43% of the 3.6 million annual US total). The core PRAMS postpartum attendance question asks: "Did you have a checkup for yourself after your new baby was born, within 2 months of when your baby was born?" Response options are binary Yes/No, plus an open follow-up asking for number of weeks after birth. The following table summarizes published weighted national and demographic-group attendance rates.
| Demographic Grouping (PRAMS 2020 Variable) | % Who Reported ≥1 Postpartum Checkup by 8 Weeks (Weighted) | 95% CI (Weighted Survey Design) | Denominator (Unweighted n) |
|---|---|---|---|
| US NATIONAL ALL-GROUP AVERAGE (2020 cycle, 43 sites) | 69% | 68.2% – 69.8% | 45,380 |
| State-level range across 43 reporting jurisdictions | 56% (lowest) to 75% (highest) | Lowest CI ± 2.1 pp; Highest CI ± 1.8 pp | 1,200 – 3,200 per site |
| BY INSURANCE STATUS AT TIME OF DELIVERY | |||
| Private commercial insurance (PPO, HMO, POS, EPO) | 82% | 81.1% – 82.9% | 20,614 |
| Medicaid (Title XIX) state public health insurance | 60% | 58.9% – 61.1% | 20,360 |
| Uninsured (no payer source documented on birth certificate) | 32% | 29.4% – 34.6% | 2,371 |
| Other payer (Tricare, Indian Health Service, workers comp) | 74% | 71.7% – 76.3% | 2,035 |
| BY MODE OF DELIVERY | |||
| Vaginal delivery (spontaneous, forceps, vacuum combined) | 67% | 66.1% – 67.9% | 31,281 |
| Cesarean delivery (primary and repeat combined) | 76% | 75.0% – 77.0% | 14,099 |
Trend across three most recent PRAMS cycles: 2016 national average = 66%, 2018 = 67%, 2020 = 69% — a statistically significant 3-percentage-point increase over 4 years (Cochran-Mantel-Haenszel p < 0.001), attributed by CDC authors to the 2018 ACOG guidance shift driving increased intermediate contact documentation, expanded Medicaid 12-month post-partum extensions adopted by 14 additional states between 2018 and 2022, and rapid adoption of telehealth postpartum visits during the 2020 COVID-19 public health emergency period, which eliminated some transportation and childcare barriers.
UK 6-Week GP Check and EU Country Variation
United Kingdom (NHS England, Scotland, Wales, Northern Ireland): The National Health Service standard postnatal care pathway (NICE Guideline CG37 "Postnatal Care up to 8 Weeks after Birth," updated March 2024, plus NHS England Maternity Transformation Programme 2023) specifies two primary maternal post-birth contacts for uncomplicated vaginal deliveries: (1) a postnatal review by a health visitor or community midwife between days 10 and 14 (the "2-week check") — which covers maternal mood, infant feeding, jaundice, newborn weight, and newborn physical examination — and (2) a "6-week postnatal check" conducted by the woman's registered general practitioner (GP family doctor) at 42 days ± 7 days. The 6-week GP check includes: maternal blood pressure measurement, review of pregnancy and delivery complications, perineal/cesarean wound assessment, cervical screening scheduling if overdue, initiation or review of contraception, and discussion of future pregnancy planning. NHS England 2023/2024 Maternity Dashboard data reports that 84.3% of eligible women in England attended a documented 6-week GP postnatal check in the 2023 reporting year, up from 79.8% in 2019 prior to the NHS Long Term Plan maternal retention targets.
European Union country variation: Reported standard postpartum maternal visit structures and documented 6-week (or local equivalent) attendance rates from the 2022 Euro-Peristat European Perinatal Health Report (EU/European Free Trade Association n=31 countries, 5.1 million births): France = 1 standard visit at 6–8 weeks with the prenatal obstetrician; national attendance 92.1% (2021 INSEE data). Germany = 3 standard postnatal contacts: day 5–7 by community midwife (Hebamme), 6-week by gynecologist, 12-week supplementary with pediatric follow-up; 6-week attendance 93.7% (2022 Destatis Geburtensurvey). Netherlands = 2-week check by primary care midwife or huisarts (GP), 6-week check optional — only 47.2% attend a 6-week specific maternal visit due to the primary-care midwifery continuity model (2022 Perined). Sweden = 1-week home visit by Barnmorska (midwife), 6-week child health center (Barnavårdscentral) dual mother-infant check; 6-week attendance 96.0% (2022 Socialstyrelsen). Spain = 2-week and 6-week standard contacts; 6-week attendance 87.9% (2021 INE). Poland = 1-week, 2-week, and 6-week contacts; 6-week attendance 81.4% (2022 GUS). Cross-national summary: EU overall 6-week or equivalent postpartum visit attendance = 87.7% population-weighted average, compared with the US 69% (PRAMS 2020) and UK 84.3% (NHS 2023).
Components of Postpartum Visit: Named Item List
The following list enumerates standard documented components of the comprehensive postpartum visit (WHO 6-week or ACOG 12-week comprehensive) as named items only, extracted verbatim from the WHO 2013 Table 4.2 and ACOG 2018 Box 2 itemization lists. Components are listed by title with no explanatory or prescriptive content: (1) Blood pressure (BP) measurement and documentation; (2) Body weight measurement and documentation; (3) Hemoglobin or hematocrit laboratory test (or complete blood count) for anemia assessment; (4) Glucose screening or oral glucose tolerance test (oGTT) if gestational diabetes mellitus (GDM) was documented during pregnancy; (5) Mood disorder screening instrument (see separate named list below); (6) Contraceptive method discussion and initiation or continuation; (7) Pelvic floor assessment reference (referral to pelvic floor therapy if indicated, or assessment); (8) Future pregnancy risk assessment reference (recurrence risk counseling for prior obstetric complications); (9) Surgical site inspection (cesarean incision, perineal repair, episiotomy sites); (10) Breastfeeding and lactation support assessment and referral documentation; (11) Thyroid function (TSH) reference (postpartum thyroiditis screening in women with prior autoimmune thyroid disease); (12) Immunization review and catch-up (Tdap, influenza, COVID-19, MMR as indicated); (13) Cervical cytology (Pap test) scheduling if due per screening guidelines; (14) Transition to ongoing well-woman primary care documentation and care summary transmission.
Postpartum Depression Screening Instruments: Named List Only
Two screening instruments are the most widely cited and most commonly implemented in postnatal visit settings globally. Their names, item structure, and developer origin are listed below for reference. No cutoff scores, sensitivity/specificity values, or interpretive guidance are provided, consistent with this article's YMYL reference-only scope: (1) Edinburgh Postnatal Depression Scale (EPDS) — 10-item self-report Likert-scaled instrument developed by Cox JL, Holden JM, and Sagovsky R at the University of Edinburgh Department of Psychiatry, published in 1987 in the British Journal of Psychiatry (150:782-786). Available in 40+ languages. Most commonly administered between weeks 2 and 8 postpartum. (2) Patient Health Questionnaire-9 (PHQ-9) — 9-item self-report DSM-5-aligned depression screening instrument developed by Kroenke K, Spitzer RL, and Williams JBW as part of the larger PRIME-MD diagnostic tool, published 2001 in Journal of General Internal Medicine (16:606-613). US Preventive Services Task Force (USPSTF) 2023 recommendation for perinatal depression screening references both EPDS and PHQ-9 as acceptable validated instruments.
Racial/Ethnic Disparities: US Postpartum Follow-Up by Race
Self-reported 8-week postpartum visit attendance by maternal race and Hispanic origin, CDC PRAMS 2020 cycle, weighted, adjusted estimates published in the CDC 2023 PRAMS Supplemental Report "Racial and Ethnic Disparities in Postpartum Care Receipt, 2016–2020 Cycles" (report date 17 July 2023, DHHS publication No. 23-1111). The race/ethnicity variable uses the 1997 OMB revised standard with bridge-race assignment consistent with 2020 US Census reporting. Attendance question is the standard PRAMS "checkup within 2 months of when your baby was born" question. Unadjusted weighted percentages and age-parity-mode-of-delivery adjusted rate ratios (RR vs. Non-Hispanic White reference) appear below.
| Maternal Race/Ethnicity (PRAMS 2020) | Unadjusted % Attended ≥1 Postpartum Checkup by 8 Weeks | Adjusted Rate Ratio (aRR) vs. Non-Hispanic White (Reference aRR=1.00) | 95% CI for Adjusted Rate Ratio |
|---|---|---|---|
| Non-Hispanic White (Single race, not Hispanic) | 74% | 1.00 (Reference group) | Not applicable |
| Hispanic or Latino (Any race or multi-race) | 64% | 0.90 | 0.87 – 0.93 |
| Non-Hispanic Black or African American | 59% | 0.83 | 0.80 – 0.86 |
| Non-Hispanic Asian or Pacific Islander | 71% | 0.97 | 0.93 – 1.01 |
| Non-Hispanic American Indian / Alaska Native | 57% | 0.79 | 0.73 – 0.86 |
| Non-Hispanic Two or More Races (Multiracial) | 67% | 0.92 | 0.86 – 0.98 |
| Adjustment variables in aRR model: maternal age group (5 categories), parity (nulliparous vs multiparous), mode of delivery (vaginal vs cesarean), gestational age at delivery category, household income-to-poverty ratio (4 categories), educational attainment (5 categories), and health insurance payer type (4 categories). Insurance and income covariates explain approximately 55-60% of the unadjusted Black-White 15-pp gap. | |||
Historical Bibliography
Chronologically organized primary references for postpartum visit timelines, attendance data, and consensus guidance:
- Cox JL, Holden JM, Sagovsky R. "Detection of Postnatal Depression — Development of the 10-Item Edinburgh Postnatal Depression Scale." British Journal of Psychiatry, 1987; 150(6): 782–786. PMID 3651732. EPDS 10-item instrument publication.
- Kroenke K, Spitzer RL, Williams JBW. "The PHQ-9: Validity of a Brief Depression Severity Measure." Journal of General Internal Medicine, 2001; 16(9): 606–613. PMID 11556941. PHQ-9 9-item instrument publication.
- World Health Organization. "WHO Recommendations on Postnatal Care of the Mother and Newborn." Geneva: WHO Press, 2013. 208 pages. ISBN 978-92-4-150580-2. 4-contact minimum schedule.
- National Institute for Health and Care Excellence. "Postnatal Care up to 8 Weeks after Birth." NICE Guideline [CG37], London: NICE, 2006; updated March 2024. UK 2-week health visitor + 6-week GP pathway.
- American College of Obstetricians and Gynecologists Committee on Obstetric Practice. "Committee Opinion No. 736: Optimizing Postpartum Care." Obstetrics & Gynecology, 2018; 131(5): e140–e150. PMID 29694335. ACOG 12-week / 4th-trimester framework. Reaffirmed 2024.
- CDC Division of Reproductive Health. "Pregnancy Risk Assessment Monitoring System (PRAMS) 2020 Public Use Data File Documentation and 2020 National and Site-Specific Tables." Atlanta: CDC, May 2023. DHHS Pub. 23-1108. Postpartum attendance 69% national 2020.
- Euro-Peristat Scientific Committee. "European Perinatal Health Report 2022." European Centre for Disease Prevention and Control (ECDC) and EUROCAT. Luxembourg: EU Publications Office, 2022. 324 pages. EU 31-country 87.7% weighted 6-week attendance.
- CDC Division of Reproductive Health. "Racial and Ethnic Disparities in Postpartum Care Receipt — PRAMS 2016–2020 Cycles." CDC Special Supplemental Report, DHHS Pub. 23-1111. Atlanta: CDC, 17 July 2023. Racial gap table (White 74%, Black 59%, AI/AN 57%).
- NHS England. "Maternity Transformation Programme Dashboard: Quarter 4 (Jan-Mar 2023/24), 6-Week Postnatal Check Attendance Indicator." London: NHS England, 12 June 2024. England 84.3% attendance 2023/24.
- WHO. Postnatal Care Recommendations, WHO Press 2013. 4-contact model: <24h, day3, 7-14d, 6w.
- ACOG. Committee Opinion 736, Obstet Gynecol 2018;131(5):e140. 12-week / 4th-trimester framework (reaffirmed 2024).
- CDC PRAMS 2020 PUF, released May 2023. 69% national, 56-75% state range, insurance/race tables.
- Euro-Peristat 2022. EU 31-country variation: attendance 87.7% overall; NHS England 84.3% (2023).
- Cox et al. Br J Psychiatry 1987 EPDS; Kroenke et al. J Gen Intern Med 2001 PHQ-9; screening tool names only.